AICDA and Miyoshi myopathy: Previous genome-wide analyses of MM/MGUS samples have also shown that mutation patterns associated with APOBEC activity correlate with disease progression and clinical outcomes11,16,17, whereas those associated with AID activity contribute to disease initiation37.